Climate and Energy Management

Climate and Energy Management

Management Approach：

Bora recognizes the challenges and responsibilities posed by climate change and is committed to taking action to reduce greenhouse gas emissions. In alignment with the TCFD framework, we disclose information on governance, strategies, and risk management related to climate issues. We conduct annual carbon inventories, develop carbon reduction plans, and implement reduction measures to minimize our operational carbon footprint. These efforts not only meet market and customer expectations for carbon reduction targets but also enhance the company’s competitiveness.

Environmental Objectives and Policy

A. Environmental Goal

1. Under the global 2050 net-zero trend, Bora Group has made energy-saving and carbon-reduction a core objective, dedicating itself to mitigating the impacts of climate change while promoting environmental protection and sustainable development.
2. Starting in 2025, the ISO-14001 environmental management system will be implemented to comprehensively enforce top-to-bottom environmental, safety, and health policy management.

B. Environmental Policy

1. Implement the carbon inventory mechanism and disclose the carbon emissions status of each subsidiary
2. Through the carbon inventory system, identify opportunities for reduction in internal and external activities of the enterprise
3. For consumers and customers, aim to implement a green supply chain
4. Consider the carbon footprint of the product’s life cycle, from raw materials to use to disposal.

C. Our Goals

Greenhouse Gas Emissions

Bora Pharmaceuticals has adopted the ISO 14064-1:2018 greenhouse gas (GHG) inventory mechanism since 2021 and has engaged a third-party organization for annual verifications. To date, the company has successfully obtained verification certificates for three consecutive years. Moving forward, Bora will use 2023 GHG emissions as the baseline year for its reduction targets and continue implementing carbon reduction initiatives.

The 2023 GHG emissions data showed noticeable fluctuations compared to 2022. This was primarily due to the inclusion of the Zhubei and Zhongli Plant 1 and 2 facilities, the expanded scope of emissions calculations, and changes in production scale. Emissions from newly integrated facilities were fully accounted for, leading to an increase in total emissions. Additionally, Sunway was integrated into Bora at the end of 2023; however, its emissions data is still being compiled and has not been included in this analysis. Further disclosures regarding these emissions are expected in the 2024 report.

Energy Management

Bora Pharmaceuticals is actively committed to reducing overall energy consumption to decrease carbon dioxide emissions. The primary sources of energy consumption for the Bora Group are purchased electricity and natural gas, with no use of heavy oil or diesel as energy sources. The electricity system mainly supplies the chiller units, air conditioning systems, and production equipment within the plants, while natural gas consumption is used for gas boilers.

Energy Consumption (GJ)

Fulfilling Environmental Commitments